Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Other Working Capital Changes: 2013-2017

Historic Other Working Capital Changes for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2017 value amounting to $143,000.

  • Tvardi Therapeutics' Other Working Capital Changes rose 104.35% to $143,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $105,000, marking a year-over-year increase of 152.76%. This contributed to the annual value of -$7.6 million for FY2024, which is 6.02% up from last year.
  • Tvardi Therapeutics' Other Working Capital Changes amounted to $143,000 in Q4 2017, which was up 132.28% from -$443,000 recorded in Q3 2017.
  • Tvardi Therapeutics' Other Working Capital Changes' 5-year high stood at $5.3 million during Q2 2013, with a 5-year trough of -$3.3 million in Q4 2016.
  • Moreover, its 3-year median value for Other Working Capital Changes was $296,000 (2017), whereas its average is -$128,833.
  • As far as peak fluctuations go, Tvardi Therapeutics' Other Working Capital Changes skyrocketed by 471.21% in 2014, and later plummeted by 1,239.13% in 2015.
  • Over the past 5 years, Tvardi Therapeutics' Other Working Capital Changes (Quarterly) stood at -$959,000 in 2013, then skyrocketed by 48.70% to -$492,000 in 2014, then crashed by 530.28% to -$3.1 million in 2015, then declined by 6.09% to -$3.3 million in 2016, then skyrocketed by 104.35% to $143,000 in 2017.
  • Its Other Working Capital Changes was $143,000 in Q4 2017, compared to -$443,000 in Q3 2017 and -$44,000 in Q2 2017.